| # | Title | Journal | Year | Citations |
|---|
| 1 | EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) | Annals of the Rheumatic Diseases | 2006 | 651 |
| 2 | Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases | 2011 | 394 |
| 3 | Consensus statement on the use of rituximab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases | 2006 | 194 |
| 4 | Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression | Seminars in Arthritis and Rheumatism | 2014 | 119 |
| 5 | Obesity as a Risk and Severity Factor in Rheumatic Diseases (Autoimmune Chronic Inflammatory Diseases) | Frontiers in Immunology | 2014 | 110 |
| 6 | Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study | Annals of the Rheumatic Diseases | 2012 | 104 |
| 7 | Body weight, gender and response to TNF- blockers in axial spondyloarthritis | Rheumatology | 2014 | 104 |
| 8 | Interleukin-1β and Interleukin-6 in Arthritis Animal Models: Roles in the Early Phase of Transition from Acute to Chronic Inflammation and Relevance for Human Rheumatoid Arthritis | Molecular Medicine | 2010 | 100 |
| 9 | MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis | Nature Communications | 2016 | 97 |
| 10 | Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis | Journal of Rheumatology | 2008 | 95 |
| 11 | Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study | Journal of Rheumatology | 2007 | 94 |
| 12 | The metabolic syndrome: The crossroads between rheumatoid arthritis and cardiovascular risk | Autoimmunity Reviews | 2011 | 90 |
| 13 | Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review | Clinical Rheumatology | 2011 | 89 |
| 14 | Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study | Frontiers in Pharmacology | 2017 | 89 |
| 15 | The need for personalised medicine for rheumatoid arthritis | Annals of the Rheumatic Diseases | 2011 | 88 |
| 16 | Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients | Clinical Rheumatology | 2016 | 83 |
| 17 | TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis | Clinical Rheumatology | 2008 | 80 |
| 18 | Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study | Internal Medicine Journal | 2020 | 75 |
| 19 | Skin ulcers in systemic sclerosis: Determinants of presence and predictive factors of healing | Journal of the American Academy of Dermatology | 2009 | 73 |
| 20 | MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis | Nature Communications | 2017 | 72 |
| 21 | Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression | Annals of the Rheumatic Diseases | 2011 | 71 |
| 22 | Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA | Frontiers in Immunology | 2018 | 71 |
| 23 | Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue | Arthritis Research and Therapy | 2013 | 55 |
| 24 | Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease | Autoimmunity Reviews | 2019 | 49 |
| 25 | Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement | Microvascular Research | 2021 | 49 |
| 26 | Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects | Annals of the Rheumatic Diseases | 2006 | 46 |
| 27 | PTPN22 1858C>T Polymorphism Distribution in Europe and Association with Rheumatoid Arthritis: Case-Control Study and Meta-Analysis | PLoS ONE | 2011 | 43 |
| 28 | Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis | Medicine (United States) | 2017 | 43 |
| 29 | Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters | Clinical Hemorheology and Microcirculation | 2015 | 38 |
| 30 | When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the International Recommendation Implementation Study (IRIS) | RMD Open | 2016 | 38 |
| 31 | Computer-Aided Quantification of Interstitial Lung Disease from High Resolution Computed Tomography Images in Systemic Sclerosis: Correlation with Visual Reader-Based Score and Physiologic Tests | BioMed Research International | 2015 | 37 |
| 32 | Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology | Annals of the Rheumatic Diseases | 2015 | 36 |
| 33 | Colour Doppler ultrasonography evaluation of vascularization in the wrist and finger joints in rheumatoid arthritis patients and healthy subjects | European Journal of Radiology | 2012 | 35 |
| 34 | Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response | Frontiers in Pharmacology | 2019 | 35 |
| 35 | Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis | PLoS ONE | 2012 | 34 |
| 36 | Rationale for T Cell Inhibition by Cyclosporin A in Major Autoimmune Diseases | Annals of the New York Academy of Sciences | 2005 | 30 |
| 37 | Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study | Journal of Clinical Endocrinology and Metabolism | 2018 | 30 |
| 38 | The association of silent thyroiditis with active systemic lupus erythematosus | Clinical and Experimental Rheumatology | 1992 | 30 |
| 39 | Craniocervical junction involvement in rheumatoid arthritis: a clinical and radiological study | Journal of Rheumatology | 2000 | 30 |
| 40 | ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature | Arthritis Research and Therapy | 2009 | 29 |
| 41 | Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors | Lupus | 2008 | 27 |
| 42 | Benefit/risk of cyclosporine in rheumatoid arthritis | Clinical and Experimental Rheumatology | 2004 | 26 |
| 43 | Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis | Annals of the Rheumatic Diseases | 2009 | 24 |
| 44 | Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features | Frontiers in Medicine | 2018 | 24 |
| 45 | What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? | Autoimmunity Reviews | 2020 | 24 |
| 46 | Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2012 | 23 |
| 47 | Quality indicators in rheumatoid arthritis: results from the METEOR database | Rheumatology | 2015 | 23 |
| 48 | Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis | Frontiers in Medicine | 2018 | 23 |
| 49 | Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein | Clinical Rheumatology | 2012 | 21 |
| 50 | Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes | Frontiers in Medicine | 2020 | 21 |
